Sotera Health (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Analysts

Shares of Sotera Health (NASDAQ:SHC) have received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $16.50.

A number of equities analysts have recently weighed in on SHC shares. Citigroup upped their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Tuesday, August 6th. Finally, Barclays upped their target price on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 6th.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 55.12% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Wedmont Private Capital lifted its position in shares of Sotera Health by 6.5% during the 3rd quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock valued at $169,000 after buying an additional 664 shares during the last quarter. First Citizens Bank & Trust Co. lifted its position in shares of Sotera Health by 5.0% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock valued at $239,000 after buying an additional 677 shares during the last quarter. CWM LLC lifted its position in shares of Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares during the last quarter. Swiss National Bank lifted its position in shares of Sotera Health by 0.5% during the 1st quarter. Swiss National Bank now owns 195,900 shares of the company’s stock valued at $2,353,000 after buying an additional 1,000 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after buying an additional 1,660 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of SHC opened at $15.32 on Thursday. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business’s 50 day moving average price is $16.00 and its two-hundred day moving average price is $13.83. The firm has a market cap of $4.34 billion, a PE ratio of 61.28 and a beta of 2.08.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same period last year, the firm posted $0.18 earnings per share. Sotera Health’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, equities analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.